Inbox Robot: Acute Lymphocytic Leukemia News http://www.inboxrobot.com/news/acute-lymphocytic-leukemiaConstantly updated news and information about a variety of topics. Callisto Pharmaceuticals Announces $3.0 Million Financing by Its Synergy Pharmaceuticals Subsidiary and Related Transactions Leaving http://www.inboxrobot.com/news.php?fid=179588858 21 Jul 2008 23:14 GMT ... a Phase I clinical trial in children and young adults with refractory or relapsed acute lymphocytic leukemia or acute myelogenous leukemia. Callisto is also listed on the Frankfurt Stock Exchange under ... Callisto Pharmaceuticals Announces $3.0 Million Financing by Its Synergy Pharmaceuticals Subsidiary and Related Transactions Leaving Callisto with a 68% Stake in Synergy http://www.inboxrobot.com/news.php?fid=179526375 21 Jul 2008 15:54 GMT ... a Phase I clinical trial in children and young adults with refractory or relapsed acute lymphocytic leukemia or acute myelogenous leukemia. Callisto is also listed on the Frankfurt Stock Exchange under ... Pawfect Foods Announces Acquisition of Synergy Pharmaceuticals and $3.0 Million Financing http://www.inboxrobot.com/news.php?fid=179523026 21 Jul 2008 15:30 GMT ... a Phase I clinical trial in children and young adults with refractory or relapsed acute lymphocytic leukemia or acute myelogenous leukemia. Callisto is also listed on the Frankfurt Stock Exchange under ...